Rare disease status update: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
Line 19: Line 19:
==List of Chapters Requiring Content==
==List of Chapters Requiring Content==


{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center"
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Category}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Category}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Chapters that need content}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Chapters that need content}}
Line 29: Line 29:
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Reviewer name}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Reviewer name}}
|-
|-
| rowspan="999" |Rare disease
| rowspan="1000" |Rare disease
| style="padding: 5px 5px; background: #F5F5F5;" |Abetalipoproteinemia
| style="padding: 5px 5px; background: #F5F5F5;" |Abetalipoproteinemia
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
Line 189: Line 189:
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;" |  
|-
|ACTH Deficiency
|
|
|
|
|
|
|-
|-


==In-Progress Chapters==
==In-Progress Chapters==


{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
 
|}{| style="border: 0px; font-size: 90%; margin: 3px;" align=center
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Category}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Category}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Chapters that need content}}
! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | {{fontcolor|#FFFFFF|Chapters that need content}}

Revision as of 06:08, 22 July 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]

System Leader: Vamsikrishna Gunnam M.B.B.S [3]

Progress
Completed 157
In progress 2
Remaining 1079

List of Chapters Requiring Content

In-Progress Chapters

Category Chapters that need content Assignment status Scholar name Coach name Completion status Review status Reviewer name
Rare disease Abetalipoproteinemia
Ablepharon-Macrostomia Syndrome
Acanthocheilonemiasis
Acanthosis Nigricans
Aceruloplasminemia
Acid Sphingomyelinase Deficiency
Achard Thiers Syndrome
Achondrogenesis
Achondroplasia
Acidemia Isovaleric
Acidemia, Methylmalonic
Acquired Aplastic Anemia
Acquired Hemophilia
Acquired Lipodystrophy
Acquired Neuromyotonia
Acrocallosal Syndrome, Schinzel Type
Acrodermatitis Enteropathica
Acrodysostosis
Acromesomelic Dysplasia
Acromicric Dysplasia
ACTH Deficiency

{| style="border: 0px; font-size: 90%; margin: 3px;" align=center

! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | Category ! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | Chapters that need content ! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | Assignment status ! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | Scholar name ! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | Coach name ! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | Completion status ! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | Review status ! style="background: #4479BA; padding: 5px 5px;" rowspan=1 | Reviewer name |- | rowspan="999" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" | Rare disease | style="padding: 5px 5px; background: #F5F5F5;" | SIDS | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | style="padding: 5px 5px; background: #F5F5F5;" |Krishna | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | |- | style="padding: 5px 5px; background: #F5F5F5;" |Erdheim Chester disease | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | style="padding: 5px 5px; background: #F5F5F5;" |Mojdeh | style="padding: 5px 5px; background: #F5F5F5;" |Sogand | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | |- | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | |- | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | |- | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | |- | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | |- | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | |- | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | |- | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | |- | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | |- | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | |- | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | |- | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | |- | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | |- | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | |- | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | |- | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | |- | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | |- | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | |- | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | | style="padding: 5px 5px; background: #F5F5F5;" | |- |}

Completed Chapters

Category Chapters that need content Assignment status Scholar name Coach name Completion status Review status Reviewer name
Rare disease Bernard-Soulier Syndrome Krishna Gunnam Completed Done Farima
Blue Rubber Bleb Nevus syndrome Krishna Gunnam Completed Done Anmol
Hairy Cell Leukemia Krishna Gunnam Completed
Hutchinson-Gilford Progeria Krishna Gunnam Completed
Joubert Syndrome Krishna Gunnam Completed
Merkel Cell Carcinoma Krishna Gunnam Completed
Timothy Syndrome Krishna Gunnam Completed Done Mahshid mir
Wyburn-Mason Syndrome Krishna Gunnam Completed
Romano-Ward syndrome Krishna Gunnam Completed
Jervell and Lange-Nielsen syndrome Krishna Gunnam Completed
Timothy syndrome Krishna Gunnam Completed
Andersen-Tawil syndrome Krishna Gunnam Completed
Ameloblastoma Krishna Gunnam Completed Done Fahimeh
Aarskog-Scott syndrome Krishna Gunnam Completed
Acromegaly Elsaiey Completed
Acoustic Neuroma Mohsen Completed
Acute Myeloid Leukemia Shyam patel Completed Done Natalie Harpenau
Retrieved from "https://www.wikidoc.org/index.php?title=Rare_disease_status_update&oldid=1630878"